期刊文献+

三阴性乳腺癌中MMP-9及E-cadherin表达的意义 被引量:7

Significance of the expression of MMP-9 and E-cadherin in triple negative breast cancer
暂未订购
导出
摘要 目的:探讨三阴性乳腺癌( TNBC)中基质金属蛋白酶-9( MMP-9)及E-钙粘蛋白( E-cadherin)表达情况及二者与TNBC临床病理特征的关系,从而分析MMP-9与E-cadherin在TNBC发生发展中的作用。方法应用免疫组化法检测127例TNBC组织中MMP-9和E-cadherin的表达情况。结果 TNBC中MMP-9阳性表达率为53.54%,E-cadherin阳性表达率为32.28%。 MMP-9的表达与肿瘤大小(P=0.007),组织学分级(P=0.006),临床分期(P=0.003),淋巴结转移(P=0.000)和淋巴管浸润(P=0.015)相关。 E-cadherin的表达与淋巴结转移(P=0.016)和淋巴管浸润(P=0.021)相关。同时统计结果显示二者表达与其他因素无相关性( P>0.05)。结论 MMP-9和E-cadherin与TNBC的浸润和转移有关,可能成为TNBC靶向治疗的研究靶点。 Objective To investigate the expression of matrixmetalloprotein -9(MMP-9)and E-cad-herin in triple negative breast cancer ( TNBC) and its relationship with the clinicopathologic features of TNBC .To analyze the function of MMP -9 and E-cadherin in TNBC .Methods Immunohistochemical method was used to detect the expression of MMP -9 and E-cadherin in 127 cases of TNBC.Results The MMP-9 positive rate was 53.54%and E-cadherin positive grade was 32.28%in TNBC.Expression of MMP-9 was correlated with tumor size(P=0.007),histological grade(P=0.006),TNM stage(P=0.003),lymph node metastasis(P=0.000)and lymph duct invasive(P=0.000).Expression of E-cadherin was correlated with lymph node metasta-sis(P=0.016)and lymph duct invasive(P=0.015).However,they were not correlated with other factors .Con-clusion The expression of MMP -9 and E -cadherin was correlated with invasion and metastasis in TNBC , which could be an important research topic in the future studies .
出处 《实用肿瘤学杂志》 CAS 2014年第1期19-23,共5页 Practical Oncology Journal
基金 第六届大学生创新创业训练计划项目(201210226042)
关键词 三阴性乳腺癌 基质金属蛋白酶-9 E-钙粘蛋白 浸润 转移 Matrixmetalloprotein-9 Triple negative breast cancer E-cadherin Invasion Metastasis
  • 相关文献

参考文献16

二级参考文献92

  • 1李宏江,敬静,汪静,吕青,陈琳,赵扬冰.乳腺肿瘤中VEGF的表达和MVD分布[J].四川大学学报(医学版),2005,36(2):288-289. 被引量:20
  • 2谢海健,钟雪云,杜彬,李红,郑佩娥.贲门癌中转移相关基因MTA1表达的临床病理研究[J].广东医学,2005,26(5):635-636. 被引量:1
  • 3李孟圈,李靖若,鲍俊涛,苏静,李建章.MTA1蛋白在乳腺癌中的表达及临床意义[J].山东医药,2007,47(15):17-19. 被引量:2
  • 4Achen MG,Stacker SA.Molecular control of lymphatic metastasis.Ann N Y Acad Sci,2008,1131:225-234.
  • 5Jones JL,Glynn P,Walker RA.Expression of MMP-2 and MMP-9,their inhibitors,and the activator MT1-MMP in primary breast carcinomas.J Pathol,1999,189(2):161-168.
  • 6Sliwowska I,Kopczynski Z.Zymography-method for quantitation of activity on gelatinese A(pro-MMP-2,72 kDa)and gelatinase B(pro-MMP-9,92 kDa)in serum of patients with breast cancer.Wiad Lek,2007,60(5-6):241-247.
  • 7Kurizaki T,Toi M,Tominage T.Relationship between matrix metalloproteiuase expression and tumor angiogenesis in human breast carcinoma.Oncol Rep,1998,5(3):673-677.
  • 8Tavassoli FA,Devilec P.World Health Organization classification of tumours.Pathology and genetics turnouts of the breast and femal genital organ.Lyon:IARC Press,2003:10.
  • 9Livak K J,Schmittgen TD.Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T))method.Methods,2001,25(4):402-408.
  • 10Banerjee M,George J,Song EY,et al.Tree-besod model for breast cancer prognostication.J Clin Oncol,2004,22(13):2567-2575.

共引文献61

同被引文献56

引证文献7

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部